Home Our offer Dossier creation

Dossier creation

Alcimed helps its customers in the dossier creation of financial applications for their innovation and research and development projects (H2020, Eurostars, Eurêka, FEDER, FSE, PIA, PSPC, France Relance, ANR, ADEME, Bpifrance, …).

Have a project? Contact our team!

Dossier creation Agency Consulting firm Experts Specialists

How we help you in your dossier creation and application process

Alcimed assists its clients in the setting up of R&D&I (Research-Development-Innovation) funding applications in response to local, national or European calls for projects. This is a crucial step essential to the launch of an innovation project. This is why it requires time and specific skills. Alcimed supports you in your response to calls for projects or expressions of interest. Our teams support you in the identification of the right financing window, the definition and structuring of your innovation project in response to the expectations of the potential financier, the search for partners, the preparation of the file and the follow-up of its instruction.

Contact us!


We have supported numerous award-winning “university-hospital research” (RHU) projects in various indications around the treatment of autoimmune diseases, rare genetic diseases, cancers and genetic sensory diseases. In the context of setting up a RHU project, we intervene upstream to challenge the positioning, the clinical question addressed and the scientific method developed, as well as to define the deliverables. Our team then assists you in the negotiation and framing phases of the partner consortium, drawing on our knowledge of industrial issues. Finally, we intervene in the dossier creation phase by acting as both facilitator and coordinator of the entire set-up of the RHU project with the entire consortium, and by taking charge of the key phases of the project: development strategy, medico-economic aspects, financial framework, etc. Finally, we provide a critical review at the end of the creation of the dossier.
Support during the setting up of the H2020 BoneRegTech project, on the dimensions ‘market research, setting up and coordination of the different partners (distribution of tasks and responsibilities between the project partners as well as setting up a drafting and validation process)’. Our team also carried out a critical rereading of the “scientific excellence” part of the file and more generally identified tracks of improvement based on our experience. We also contributed to the “management” part of the document and wrote the “impact” part, in collaboration with the project coordinator and the other members of the partnership. Alcimed then submitted the H2020 application on time and in the form expected by the European Commission, for a positive result in the end!
Our team assisted the project leaders of an incubator in mapping the public and private innovation financing mechanisms available and in the preparation of financing applications. We first worked on the identification and characterization of public innovation financing windows in France and Europe: funder, eligibility criteria, associated amounts, and types of aid. Secondly, our team identified and characterized the private seed and fund-raising schemes associated with the development of innovation in France, ultimately enabling our client to select the appropriate funding channels for its various projects. Our team then assisted the project leaders in drafting their financing files.
Our team has assisted project leaders in the preparation of a “Eurostars” funding application and the search for French and European industrial partners. Alcimed carried out a diagnosis of the current state of the project and then assisted the project leaders in identifying and structuring partnerships (establishing contacts and developing the consortium). Following this, we wrote the response file to the call for projects (AAP), in collaboration with the project leaders on the non-scientific parts, and proceeded to a global critical review, until the final file was sent. Our support allowed our client to structure its approach from A-to-Z and to guarantee an optimization of the content and form of its financial file.
We have supported two French regions in the construction of an application file for the ERDF ESF OP with a view to the deployment of a “Living Lab”. Our team identified and mobilized the key local actors and then organized working meetings in the form of workshops in order to design a “Living Lab,” meeting the expectations of the funding client and the holder of the AAP. This work allowed for the construction of the financial file and the implementation schedule. Alcimed proposed a legal structure (operator, evolution towards a SCIC) and built a viable and sustainable economic business model. This work allowed our client to define the governance of the future “Living Lab” and to raise the necessary funds for its creation.


Founded in 1993, Alcimed is an innovation and new business consulting firm, specializing in innovation driven sectors: life sciences (healthcare, biotech, agrifood), energy, environment, mobility, chemicals, materials, cosmetics, aeronautics, space and defence.

Our purpose? Helping both private and public decision-makers explore and develop their uncharted territories: new technologies, new offers, new geographies, possible futures, and new ways to innovate.

Located across eight offices around the world (France, Europe, Singapore and the United States), our team is made up of 220 highly-qualified, multicultural and passionate explorers, with a blended science/technology and business culture.

Our dream? To build a team of 1,000 explorers, to design tomorrow's world hand in hand with our clients.


    You have a project and want to discuss it with our explorers, write us ! One of our explorers will contact you shortly.


    Our explorations